Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Company announcement

Arecor appoints Jim Macdonald-Clink As Vice President, Business Development

Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces the appointment of Jim MacDonald-Clink as Vice President, Business Development with immediate effect. 

Read the rest of entry »

Arecor and JDRF sign a joint research, development and commercialisation agreement to develop a co-formulation insulin for the treatment of diabetes

Arecor Ltd, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that it has signed a Research, Development and Commercialisation agreement with JDRF, the leading global organization funding type 1 diabetes (T1D) research.

Read the rest of entry »

Mary Ann Liebert Publishers: PHAGE: Therapy, Applications, and Research

The only peer-reviewed journal dedicated to bacteriophage research and its applications in medicine, agriculture, aquaculture, veterinary applications, animal production, food safety, and food production.

Read the rest of entry »

Arecor: Signs A New Formulation Evaluation Agreement With An Existing Partner, A Major Global Pharmaceutical Company

Arecor Limited, the specialty pharmaceutical company, leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company.

Read the rest of entry »

Physiomics: Agreement with Bicycle and Cancer Research UK

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it has signed an agreement to work with Bicycle Therapeutics and Cancer Research UK.

Read the rest of entry »

CHAIN Biotechnology: Cancer vaccine firm Oxford Vacmedix announces collaboration and Innovate UK grant

Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today the award of an Innovate UK grant to CHAIN Biotechnology Ltd (CHAIN) and the University of Oxford to develop live biotherapeutics that support oral delivery for OVM’s recombinant overlapping peptide (ROP) cancer vaccines.

Read the rest of entry »

Instinctif Partners makes Managing Partner Promotions

Instinctif Partners’ Corporate and Capital Markets practice has made two Managing Partner promotions in its UK business.

Read the rest of entry »

Leaf Expression Systems Launch First Line of Hypertrans® Research Products

29 May 2019: Norwich, UK Leaf Expression Systems, a contract development and manufacturing organisation specialising in the plant-based expression and production of proteins, vaccines, metabolites and complex natural proteins, has announced the launch of its online list of products available for purchase by researchers working within the life sciences and agricultural industries.

Read the rest of entry »

Blue Earth Diagnostics continues to expand access to Axumin® (fluciclovine (18F)) in Europe

Oxford, UK – May 9, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced expanded access to Axumin® (fluciclovine (18F)) in Europe. The first commercial production of Axumin in Belgium occurred recently, with the first Belgian patients being dosed.

Read the rest of entry »

CHAIN Appoints New Non-Executive Directors

MARLOW & NOTTINGHAM, UK. -- April 8, 2019 – UK microbiome therapeutics company CHAIN Biotechnology has appointed two new non-executive directors, Dr Nel Moore and Dr Robert Haigh to the Board.

Read the rest of entry »

Pages: Previous1234567...20NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.